The independent effects of diet and exercise in the progression of chronic liver disease
Not Applicable
Completed
- Conditions
- on-alcoholic fatty liver disease (NAFLD)Non-alcoholic fatty liver disease (NAFLD)Diet and Nutrition - ObesityOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12612001087842
- Lead Sponsor
- Princess Alexandra Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Biopsy proven Nonalcoholic fatty liver disease
BMI>25kg/m2
Non-diabetic
Exclusion Criteria
Exclusion criteria included the presence of other liver diseases or evidence of cirrhosis, alcohol consumption > 40 g/day (males) or > 20 g/day (females), and diabetes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie diet and exercise effects on NAFLD progression in ACTRN12612001087842?
How do diet and exercise interventions compare to standard-of-care in managing NASH liver histology?
Which biomarkers correlate with improved cardiometabolic outcomes in NASH patients undergoing lifestyle interventions?
What adverse events are associated with combined diet-exercise regimens for NAFLD and how are they managed?
Are there synergistic effects between specific dietary patterns and exercise protocols in reducing hepatic steatosis and inflammation?